PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.54%
Positive revenue growth while XRF.AX is negative. John Neff might see a notable competitive edge here.
870.69%
Positive gross profit growth while XRF.AX is negative. John Neff would see a clear operational edge over the competitor.
184.02%
Positive EBIT growth while XRF.AX is negative. John Neff might see a substantial edge in operational management.
184.02%
Positive operating income growth while XRF.AX is negative. John Neff might view this as a competitive edge in operations.
167.73%
Net income growth above 1.5x XRF.AX's 13.78%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
166.67%
EPS growth above 1.5x XRF.AX's 12.54%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
166.67%
Diluted EPS growth above 1.5x XRF.AX's 12.54%. David Dodd would see if there's a robust moat protecting these shareholder gains.
5.78%
Share count expansion well above XRF.AX's 1.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
4.44%
Diluted share count expanding well above XRF.AX's 1.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-33.08%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.69%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
377.61%
10Y revenue/share CAGR above 1.5x XRF.AX's 151.40%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
94.32%
5Y revenue/share CAGR 1.25-1.5x XRF.AX's 74.52%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
204.39%
3Y revenue/share CAGR above 1.5x XRF.AX's 49.22%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
440.27%
10Y OCF/share CAGR above 1.5x XRF.AX's 132.15%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
90.13%
Below 50% of XRF.AX's 1139.05%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
154.99%
3Y OCF/share CAGR similar to XRF.AX's 144.47%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
525.64%
Net income/share CAGR above 1.5x XRF.AX's 198.79% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
179.66%
5Y net income/share CAGR similar to XRF.AX's 195.12%. Walter Schloss might see both on parallel mid-term trajectories.
4980.00%
3Y net income/share CAGR above 1.5x XRF.AX's 72.97%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1810.25%
10Y equity/share CAGR above 1.5x XRF.AX's 74.40%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
133.00%
5Y equity/share CAGR above 1.5x XRF.AX's 52.04%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
79.76%
3Y equity/share CAGR above 1.5x XRF.AX's 30.57%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
69.47%
Our AR growth while XRF.AX is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-25.49%
Inventory is declining while XRF.AX stands at 4.59%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.76%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
13.22%
Positive BV/share change while XRF.AX is negative. John Neff sees a clear edge over a competitor losing equity.
-24.28%
We’re deleveraging while XRF.AX stands at 35.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
71.78%
We expand SG&A while XRF.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.